Literature DB >> 16473512

Sustained astrocytic clusterin expression improves remodeling after brain ischemia.

Anouk Imhof1, Yves Charnay, Philippe G Vallet, Bruce Aronow, Eniko Kovari, Lars E French, Constantin Bouras, Panteleimon Giannakopoulos.   

Abstract

Clusterin is a glycoprotein highly expressed in response to tissue injury. Using clusterin-deficient (Clu-/-) mice, we investigated the role of clusterin after permanent middle cerebral artery occlusion (MCAO). In wild-type (WT) mice, clusterin mRNA displayed a sustained increase in the peri-infarct area from 14 to 30 days post-MCAO. Clusterin transcript was still present up to 90 days post-ischemia in astrocytes surrounding the core infarct. Western blot analysis also revealed an increase of clusterin in the ischemic hemisphere of WT mice, which culminates up to 30 days post-MCAO. Concomitantly, a worse structural restoration and higher number of GFAP-reactive astrocytes in the vicinity of the infarct scar were observed in Clu-/- as compared to WT mice. These findings go beyond previous data supporting a neuroprotective role of clusterin in early ischemic events in that they demonstrate that this glycoprotein plays a central role in the remodeling of ischemic damage.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16473512     DOI: 10.1016/j.nbd.2005.11.009

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  19 in total

1.  PCSK9 reduces the protein levels of the LDL receptor in mouse brain during development and after ischemic stroke.

Authors:  Estelle Rousselet; Jadwiga Marcinkiewicz; Jasna Kriz; Ann Zhou; Mary E Hatten; Annik Prat; Nabil G Seidah
Journal:  J Lipid Res       Date:  2011-04-25       Impact factor: 5.922

2.  Increase in clusterin-containing follicles in the adenohypophysis of drug abusers.

Authors:  Takaki Ishikawa; Bao-Li Zhu; Satoru Miyaishi; Hideo Ishizu; Hitoshi Maeda
Journal:  Int J Legal Med       Date:  2006-11-18       Impact factor: 2.686

3.  Increased clusterin expression in Fuchs' endothelial dystrophy.

Authors:  Ula V Jurkunas; Maya S Bitar; Ian Rawe; Deshea L Harris; Kathryn Colby; Nancy C Joyce
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-03-31       Impact factor: 4.799

4.  The NADPH oxidase NOX4 drives cardiac differentiation: Role in regulating cardiac transcription factors and MAP kinase activation.

Authors:  Jian Li; Michael Stouffs; Lena Serrander; Botond Banfi; Esther Bettiol; Yves Charnay; Klaus Steger; Karl-Heinz Krause; Marisa E Jaconi
Journal:  Mol Biol Cell       Date:  2006-06-14       Impact factor: 4.138

5.  From Analysis of Ischemic Mouse Brain Proteome to Identification of Human Serum Clusterin as a Potential Biomarker for Severity of Acute Ischemic Stroke.

Authors:  Hailong Song; Hui Zhou; Zhe Qu; Jie Hou; Weilong Chen; Weiwu Cai; Qiong Cheng; Dennis Y Chuang; Shanyan Chen; Shuwei Li; Jilong Li; Jianlin Cheng; C Michael Greenlief; Yuan Lu; Agnes Simonyi; Grace Y Sun; Chenghan Wu; Jiankun Cui; Zezong Gu
Journal:  Transl Stroke Res       Date:  2018-11-21       Impact factor: 6.829

6.  Apolipoproteins in the brain: implications for neurological and psychiatric disorders.

Authors:  David A Elliott; Cyndi Shannon Weickert; Brett Garner
Journal:  Clin Lipidol       Date:  2010-08-01

7.  Low clusterin levels in high-density lipoprotein associate with insulin resistance, obesity, and dyslipoproteinemia.

Authors:  Andrew N Hoofnagle; Mingyuan Wu; Albina K Gosmanova; Jessica O Becker; Ellen M Wijsman; John D Brunzell; Steven E Kahn; Robert H Knopp; Timothy J Lyons; Jay W Heinecke
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-09-16       Impact factor: 8.311

8.  Downstream targets of methyl CpG binding protein 2 and their abnormal expression in the frontal cortex of the human Rett syndrome brain.

Authors:  Joanne H Gibson; Barry Slobedman; Harikrishnan K N; Sarah L Williamson; Dimitri Minchenko; Assam El-Osta; Joshua L Stern; John Christodoulou
Journal:  BMC Neurosci       Date:  2010-04-26       Impact factor: 3.288

9.  A potential endophenotype for Alzheimer's disease: cerebrospinal fluid clusterin.

Authors:  Yuetiva Deming; Jian Xia; Yefei Cai; Jenny Lord; Peter Holmans; Sarah Bertelsen; David Holtzman; John C Morris; Kelly Bales; Eve H Pickering; John Kauwe; Alison Goate; Carlos Cruchaga
Journal:  Neurobiol Aging       Date:  2015-09-25       Impact factor: 4.673

10.  Clusterin is a ligand for apolipoprotein E receptor 2 (ApoER2) and very low density lipoprotein receptor (VLDLR) and signals via the Reelin-signaling pathway.

Authors:  Christian Leeb; Christine Eresheim; Johannes Nimpf
Journal:  J Biol Chem       Date:  2013-12-31       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.